VASO-OCCLUSIVE DEVICES WITH IN-SITU STIFFENING
    63.
    发明申请
    VASO-OCCLUSIVE DEVICES WITH IN-SITU STIFFENING 审中-公开
    VASO-OCCLUSIVE设备,具有现场强化功能

    公开(公告)号:WO2012161953A3

    公开(公告)日:2013-03-28

    申请号:PCT/US2012036894

    申请日:2012-05-08

    Abstract: A vaso - occlusive device (10) includes a first coil (12) made from a first substantially non - expansile material, and a second coil (14) at least partially co-wound with the first coil (12) and made from a second expansile material. The second coil (14) has a contracted state and an expanded state, in which the second coil (14) expands radially and/or longitudinally. The vaso - occlusive device (10) has increased stiffness when the second coil (14) is in its expanded state.

    Abstract translation: 血管闭塞装置(10)包括由第一基本上非膨胀材料制成的第一线圈(12)和与第一线圈(12)至少部分共同缠绕并由第二线圈 膨胀材料 第二线圈(14)具有收缩状态和膨胀状态,其中第二线圈(14)径向和/或纵向膨胀。 当第二线圈(14)处于其膨胀状态时,血管闭塞装置(10)具有增加的刚度。

    MEDICAL/SURGICAL POWERED HANDPIECE FOR ROTATING THE SHAFT OF A ACCESSORY, THE HANDPIECE HAVING A COUPLING ASSEMBLY THAT FACILITATES THE FINE OR COARSE ADJUSTMENT OF THE EXTENSION OF THE ACCESSORY SHAFT
    66.
    发明申请
    MEDICAL/SURGICAL POWERED HANDPIECE FOR ROTATING THE SHAFT OF A ACCESSORY, THE HANDPIECE HAVING A COUPLING ASSEMBLY THAT FACILITATES THE FINE OR COARSE ADJUSTMENT OF THE EXTENSION OF THE ACCESSORY SHAFT 审中-公开
    医疗/外科手术用于旋转附件的手柄,具有联接组件的手术装置可以有助于调整附件轴的延伸或调整

    公开(公告)号:WO2010028001A3

    公开(公告)日:2010-11-11

    申请号:PCT/US2009055670

    申请日:2009-09-02

    Inventor: MCCOMBS DANIEL L

    Abstract: A surgical tool system including a handpiece with a motor and a cutting accessory with a shaft that is rotated by the handpiece motor. The handpiece includes a coupling assembly with plural locking elements for holding the accessory shaft to an output drive shaft that is actuated by the handpiece motor. The locking elements are longitudinally spaced apart from each other. The accessory shaft is formed with retention features against which the handpiece locking elements engage. The shaft retention features are in columns. The retention features in adjacent retention features are longitudinally offset from each other. This allows the coarse or fine adjustment of the extent to which the accessory shaft extends forward from the handpiece coupling assembly.

    Abstract translation: 一种手术工具系统,包括具有马达的手持件和具有由所述手持电机旋转的轴的切割附件。 手持件包括具有多个锁定元件的联接组件,用于将附件轴保持在由手持式电动机致动的输出驱动轴上。 锁定元件彼此纵向间隔开。 附件轴形成有保持特征,手持件锁定元件与该保持特征接合。 轴保留特征是列。 相邻保留特征中的保持特征彼此纵向偏移。 这允许粗调或微调辅助轴从手持件联接组件向前延伸的程度。

    A PATIENT SUPPORT SURFACE WITH TURN-ASSIST
    69.
    发明申请
    A PATIENT SUPPORT SURFACE WITH TURN-ASSIST 审中-公开
    一个患者支持表面与转向辅助

    公开(公告)号:WO2008061228A3

    公开(公告)日:2008-12-04

    申请号:PCT/US2007084969

    申请日:2007-11-16

    Abstract: A patient support apparatus includes a support surface, which includes at least one fluid bladder and a recess, and a fluid delivery system configured to deliver fluid to the bladder, with at least a portion of the fluid delivery system being located in the recess. The fluid delivery system includes a pump having a fluid output and a fluid input. The apparatus further includes a chamber wall that defines a chamber in fluid communication with the fluid input or output of the pump, with the chamber wall absorbing vibration from the pump when the pump is operated to output fluid at its fluid output.

    Abstract translation: 患者支撑设备包括支撑表面和流体输送系统,所述支撑表面包括至少一个流体囊和凹部,所述流体输送系统构造成将流体输送到膀胱,其中流体输送系统的至少一部分位于凹部中。 流体输送系统包括具有流体输出和流体输入的泵。 该设备还包括腔室壁,该腔室壁限定与泵的流体输入或输出流体连通的腔室,当泵被操作以在其流体输出端输出流体时,腔室壁吸收来自泵的振动。

    SUSTAINED-RELEASE FORMULATIONS COMPRISING CRYSTALS, MACROMOLECULAR GELS, AND PARTICULATE SUSPENSIONS OF BIOLOGIC AGENTS
    70.
    发明申请
    SUSTAINED-RELEASE FORMULATIONS COMPRISING CRYSTALS, MACROMOLECULAR GELS, AND PARTICULATE SUSPENSIONS OF BIOLOGIC AGENTS 审中-公开
    包含结晶,大分子凝胶和生物代谢的颗粒悬浮液的持续释放配方

    公开(公告)号:WO2008082563A3

    公开(公告)日:2008-11-27

    申请号:PCT/US2007025956

    申请日:2007-12-19

    CPC classification number: A61K38/1875 A61K9/0024 A61K9/14 A61K38/18

    Abstract: The present invention is directed to sustained release formulations of biologic agents which permit persistent bioavailability. Preferred biologic agents include bone morphogenetic proteins. Diseases susceptible to amelioration and/or treatment with the formulations of the present invention include skeletal tissue diseases such as, but not limited to, osteoarthritis and other osteochondral diseases. The sustained release formulations of the present invention are especially suitable for treatment of minimally-vascularized or non- vascularized tissue sites such as, but not limited to, intrajoint, interarticular, or intraminiscal sites.

    Abstract translation: 本发明涉及允许持续生物利用度的生物制剂的持续释放制剂。 优选的生物制剂包括骨形态发生蛋白。 易于改善和/或用本发明制剂治疗的疾病包括骨骼组织疾病,例如但不限于骨关节炎和其它骨软骨病。 本发明的持续释放制剂特别适用于治疗最小血管化或非血管化的组织部位,例如但不限于闭合内,关节内或腹膜内部位。

Patent Agency Ranking